Clinical Trial Detail

NCT ID NCT03068624
Title Study of Cellular Adoptive Immunotherapy Using Autologous CD8+ Antigen-Specific T Cells and Anti-CTLA4 for Patients With Metastatic Uveal Melanoma
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors M.D. Anderson Cancer Center
Indications

uveal melanoma

Therapies

Aldesleukin + Cyclophosphamide + Ipilimumab

Age Groups: adult senior

No variant requirements are available.